SCHEMBL26459479

SCHEMBL26459479

CS(=O)(=O)c1cc(/N=N\c2ccc(O)c3ccccc23)ccc1/C=C\c1ccc(/N=N\c2ccc(O)c3ccccc23)cc1S(=O)(=O)O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SENP2 Q9HC62 6/20 0.70
▸ SENP1 Q9P0U3 6/20 0.70
▸ SENP3 Q9H4L4 5/20 0.70
▸ SUMO2 P61956 4/20 0.70
▸ SUMO1 P63165 4/20 0.70
▸ SENP7 Q9BQF6 4/20 0.70
▸ GLO1 Q04760 4/20 0.51
▸ RAD1 O60671 1/20 0.47
▸ P2RY6 Q15077 1/20 0.47
▸ ATIC P31939 2/20 0.46
▸ LMNA P02545 1/20 0.46
▸ GAA P10253 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ ATM Q13315 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26459377 0.95 SENP2 (0.76) SENP2SENP1SENP3SUMO2SUMO1
SCHEMBL26459374 0.88 SENP2 (0.91) SENP2SENP1SENP3SUMO2SUMO1
SCHEMBL29473545 0.82 SENP2 (1.00) SENP2SENP1SENP3SUMO2SUMO1
SCHEMBL6339124 0.82 SENP2 (1.00) SENP2SENP1SENP3SUMO2SUMO1
SCHEMBL29554795 0.82 SENP2 (1.00) SENP2SENP1SENP3SUMO2SUMO1
SCHEMBL3958375 0.82 SENP2 (1.00) SENP2SENP1SENP3SUMO2SUMO1
SCHEMBL26460858 0.82 SENP2 (1.00) SENP2SENP1SENP3SUMO2SUMO1
SCHEMBL26459366 0.82 SENP2 (0.71) SENP2SENP1SENP3SUMO2SUMO1
SCHEMBL13856931 0.80 SENP2 (0.67) SENP2SENP1SENP3SUMO2SUMO1
SCHEMBL18586759 0.78 SENP2 (0.89) SENP2SENP1SENP3SUMO2SUMO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230127304-A1 NEW INHIBITORS FOR THE KEAP1-NRF2 PROTEIN-PROTEIN INTERACTION PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2023-04-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230127304-A1 NEW INHIBITORS FOR THE KEAP1-NRF2 PROTEIN-PROTEIN INTERACTION KEAP1, HMOX1, NFE2L2 SENP2 2951/4885SENP1 2007/4885SENP3 2753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback